Michaël Prakesch

1.1k total citations
25 papers, 609 citations indexed

About

Michaël Prakesch is a scholar working on Molecular Biology, Organic Chemistry and Pharmaceutical Science. According to data from OpenAlex, Michaël Prakesch has authored 25 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Organic Chemistry and 6 papers in Pharmaceutical Science. Recurrent topics in Michaël Prakesch's work include Fluorine in Organic Chemistry (6 papers), Chemical Synthesis and Analysis (5 papers) and Asymmetric Synthesis and Catalysis (4 papers). Michaël Prakesch is often cited by papers focused on Fluorine in Organic Chemistry (6 papers), Chemical Synthesis and Analysis (5 papers) and Asymmetric Synthesis and Catalysis (4 papers). Michaël Prakesch collaborates with scholars based in Canada, France and United States. Michaël Prakesch's co-authors include Prabhat Arya, René Grée, Danielle Grée, Shahriar Khadem, P. Thirupathi Reddy, Jyoti Prokash Nandy, Rima Al‐awar, David Uehling, Methvin Isaac and Donald M. Leek and has published in prestigious journals such as Chemical Reviews, Accounts of Chemical Research and Cancer Research.

In The Last Decade

Michaël Prakesch

25 papers receiving 601 citations

Peers

Michaël Prakesch
Paolo Di Fruscia United Kingdom
Dmitry Borkin United States
Frederick W. Goldberg United Kingdom
Andrei W. Konradi United States
Sven Ruf Germany
Edward J. Hennessy United States
Sajiv K. Nair United States
Paolo Di Fruscia United Kingdom
Michaël Prakesch
Citations per year, relative to Michaël Prakesch Michaël Prakesch (= 1×) peers Paolo Di Fruscia

Countries citing papers authored by Michaël Prakesch

Since Specialization
Citations

This map shows the geographic impact of Michaël Prakesch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaël Prakesch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaël Prakesch more than expected).

Fields of papers citing papers by Michaël Prakesch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaël Prakesch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaël Prakesch. The network helps show where Michaël Prakesch may publish in the future.

Co-authorship network of co-authors of Michaël Prakesch

This figure shows the co-authorship network connecting the top 25 collaborators of Michaël Prakesch. A scholar is included among the top collaborators of Michaël Prakesch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaël Prakesch. Michaël Prakesch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Golbourn, Brian, Ben Ho, Amanda Luck, et al.. (2024). A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors. Neuro-Oncology. 26(10). 1895–1911. 2 indexed citations
2.
Uehling, David, Babu Joseph, Kim Chan Chung, et al.. (2021). Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma. Journal of Medicinal Chemistry. 64(15). 11129–11147. 16 indexed citations
3.
Ugwu, Francisca, Thiago Vargas Seraphim, Methvin Isaac, et al.. (2020). Sorafenib as an Inhibitor of RUVBL2. Biomolecules. 10(4). 605–605. 16 indexed citations
4.
Babichev, Yael, Alessandro Datti, David Uehling, et al.. (2016). PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma. Journal of Translational Medicine. 14(1). 67–67. 42 indexed citations
5.
Jiang, Chong, et al.. (2012). Use of Kinase Inhibitors to Correct ΔF508-CFTR Function. Molecular & Cellular Proteomics. 11(9). 745–757. 29 indexed citations
6.
Zaman, Md. Badruz, David Bardelang, Michaël Prakesch, et al.. (2012). Size Reduction of CdSe/ZnS Quantum Dots by a Peptidic Amyloid Supergelator. ACS Applied Materials & Interfaces. 4(3). 1178–1181. 10 indexed citations
8.
Grinshtein, Natalie, Alessandro Datti, David Uehling, et al.. (2011). Small Molecule Kinase Inhibitor Screen Identifies Polo-Like Kinase 1 as a Target for Neuroblastoma Tumor-Initiating Cells. Cancer Research. 71(4). 1385–1395. 76 indexed citations
9.
Khadem, Shahriar, K.A. Udachin, G.D. Enright, Michaël Prakesch, & Prabhat Arya. (2009). One-pot construction of isoindolo[2,1-a]quinoline system. Tetrahedron Letters. 50(48). 6661–6664. 18 indexed citations
10.
Nandy, Jyoti Prokash, et al.. (2009). Advances in Solution- and Solid-Phase Synthesis toward the Generation of Natural Product-like Libraries. Chemical Reviews. 109(5). 1999–2060. 143 indexed citations
11.
Kumar, Niti, Krikor Bijian, Michaël Prakesch, et al.. (2009). Discovery of Indoline-Based, Natural-Product-like Compounds as Probes of Focal Adhesion Kinase Signaling Pathways. Journal of Combinatorial Chemistry. 11(2). 303–309. 19 indexed citations
12.
Prakesch, Michaël, Krikor Bijian, Valérie Campágna‐Slater, et al.. (2008). Building skeletally diverse architectures on the Indoline Scaffold: The discovery of a chemical probe of focal adhesion kinase signaling networks. Bioorganic & Medicinal Chemistry. 16(21). 9596–9602. 7 indexed citations
13.
Prakesch, Michaël, et al.. (2008). The discovery of small molecule chemical probes of Bcl-XL and Mcl-1. Bioorganic & Medicinal Chemistry. 16(15). 7443–7449. 28 indexed citations
14.
Prakesch, Michaël, et al.. (2008). Reagent-Based, Modular, Tandem Michael Approach for Obtaining Different Indoline Alkaloid-Inspired Polycyclic Architectures. Journal of Combinatorial Chemistry. 10(3). 405–420. 7 indexed citations
15.
Prakesch, Michaël, Danielle Grée, S. Chandrasekhar, & René Grée. (2005). Synthesis of Fluoro Analogues of Unsaturated Fatty Acids and Corresponding Acyclic Metabolites. European Journal of Organic Chemistry. 2005(7). 1221–1232. 15 indexed citations
16.
Prakesch, Michaël, et al.. (2004). The propargylic route as efficient entry to monofluoro and gem-difluoro compounds: mechanistic considerations. Journal of Fluorine Chemistry. 125(4). 537–541. 31 indexed citations
17.
Prakesch, Michaël, et al.. (2003). Stereoselectivity of Nitrile Oxide Cycloadditions to Chiral Allylic Fluorides: Experiment and Theory. Chemistry - A European Journal. 9(22). 5664–5672. 13 indexed citations
18.
Prakesch, Michaël, Danielle Grée, & René Grée. (2003). Synthesis and reactivity of Z and E functionalized allylic fluorides. Tetrahedron. 59(44). 8833–8841. 6 indexed citations
19.
Prakesch, Michaël, Danielle Grée, & René Grée. (2002). The Propargylic Route as a Short and Versatile Entry to Optically Active Monofluorinated Compounds. Accounts of Chemical Research. 35(3). 175–181. 36 indexed citations
20.
Prakesch, Michaël, Danielle Grée, & René Grée. (2001). Synthesis of New Optically Active Propargylic Fluorides and Application to the Enantioselective Synthesis of Monofluorinated Analogues of Fatty Acid Metabolites. The Journal of Organic Chemistry. 66(9). 3146–3151. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026